Pharsight to Work with Critical Path Institute's Polycystic Kidney Disease Consortium on Disease Progression Modeling

Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in clinical drug development, has announced they will be working with Critical Path Institute’s Polycystic Kidney Disease (PKD) Consortium to create and study quantitative models of disease progression in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

share
Facebook